Politics ❯ Trade Policy ❯ US Government ❯ Pharmaceutical Regulations

Impact on Industry

White House Secures Pfizer Deal on Drug Prices With TrumpRx Discounts and $70 Billion U.S. Investment

Tariff pressure yielded MFN Medicaid prices with direct-sale discounts, leaving the timing of consumer savings unclear.

Trump Announces 100% Tariff on Branded Drug Imports, With Carve-Out for Firms Building U.S. Plants